(Q42505583)

1 November 2017

Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration (English)

1 reference

progressive supranuclear palsy

1 November 2017

1 reference

1 reference

Ishizawa K

1

1 reference

PubMed ID

11398841

1 November 2017

Dickson DW

series ordinal

2

1 reference

1 November 2017

1 June 2001

1 reference

Journal of Neuropathology & Experimental Neurology

1 November 2017

1 reference

1 November 2017

60

1 reference

1 November 2017

6

1 reference

1 November 2017

647-657

1 reference

PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

1 November 2017

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.6.647

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.6.647

Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.6.647

Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.6.647

Filamentous aggregates in Pick's disease, progressive supranuclear palsy, and Alzheimer's disease share antigenic determinants with microtubule-associated protein, tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.6.647

Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively "exon 10" isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.6.647

Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.6.647

Corticodentatonigral Degeneration With Neuronal Achromasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.6.647

Unusual clinical presentations of cortical-basal ganglionic degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.6.647

Corticobasal degeneration with primary progressive aphasia and accentuated cortical lesion in superior temporal gyrus: case report and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.6.647

Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.6.647

Neuronal and glial tau-positive inclusions in diverse neurologic diseases share common phosphorylation characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.6.647

Immunohistochemical study of a case with progressive supranuclear palsy without ophthalmoplegia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.6.647

Inducible nitric oxide synthase (iNOS)-like immunoreactivity in argyrophilic, tau-positive astrocytes in progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.6.647

Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.6.647

Neurodegenerative disorders with extensive tau pathology: a comparative study and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.6.647

The `subcortical dementia' of progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.6.647

Psychological dysfunction accompanying subcortical dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.6.647

Frontal lobe function in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.6.647

Computed tomographic findings in progressive supranuclear palsy: correlation with clinical grade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.6.647

Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.6.647

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.6.647

Microglia: a sensor for pathological events in the CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.6.647

Neuronal degeneration and microglial reaction in the fetal and postnatal rat brain after transient maternal hypoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.6.647

Neuropathological stageing of Alzheimer-related changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.6.647

Progressive supranuclear palsy case report with pathological findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.6.647

The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.6.647

Importance of immunological and inflammatory processes in the pathogenesis and therapy of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.6.647

21 January 2018

Identifiers

DOI

10.1093/JNEN/60.6.647

1 reference

1 November 2017

1 reference

PubMed ID

11398841